The UK/Irish Atopic Eczema Systemic Therapy Register (A-STAR) was set up in 2019 as a project of the BAD. The primary objective of A-STAR is to assess the short-term and long-term safety and effectiveness of systemic atopic eczema treatments for children, young people and adults in ‘real world’ NHS practice. Secondary objectives are to assess the cost-effectiveness of these treatments and the creation of a bioresource, collecting tissue samples which can then be used for research.

Initial funding for the project came from the British Skin Foundation and the BAD. The study Coordinating Centre based at King’s College London and Guy’s & St Thomas NHS Foundation Trust.

A-STAR receives funding from pharmaceutical companies, but they are not directly involved in the study activities and not represented on the Steering Committee. More details are available on the A-STAR website.